FDA Product Code SCA: Multi-analyte Respiratory Virus Antigen Detection Test
Rapid antigen testing for multiple respiratory viruses simultaneously reduces the need for sequential single-pathogen tests. FDA product code SCA covers multi-analyte respiratory virus antigen detection systems.
These lateral flow or microfluidic assays simultaneously detect antigens from multiple respiratory pathogens — including influenza A/B, RSV, and SARS-CoV-2 — from a single nasal or nasopharyngeal swab, delivering results within 15-30 minutes without laboratory equipment.
SCA devices are Class II medical devices, regulated under 21 CFR 866.3987 and reviewed by the FDA Microbiology panel.
Leading manufacturers include ACON Laboratories, Inc., Wondfo USA Co., Ltd. and Ihealth Labs, Inc..
FDA 510(k) Cleared Multi-analyte Respiratory Virus Antigen Detection Test Devices (Product Code SCA)
About Product Code SCA - Regulatory Context
510(k) Submission Activity
12 total 510(k) submissions under product code SCA since 2024, with 11 receiving FDA clearance (average review time: 140 days).
Submission volume has increased in recent years - 12 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.